Find Clinical Trial

Home » Find Clinical Trials » Effect of Memantine 20 mg (Ebixa) and Donepezil 5 mg (Aricept) on motor cortex plasticity induced by paired associative stimulation using transcranial magnetic stimulation (TMS) in patients suffering from Mild Cognitive Impairment. A phase II monocentric, double-blind, randomised, placebo-controlled, parallel group study.

Effect of Memantine 20 mg (Ebixa) and Donepezil 5 mg (Aricept) on motor cortex plasticity induced by paired associative stimulation using transcranial magnetic stimulation (TMS) in patients suffering from Mild Cognitive Impairment. A phase II monocentric, double-blind, randomised, placebo-controlled, parallel group study.

← Back

Study Phase	Phase 2

Therapeutic Area	Neuropsychiatric Diseases

Indication	Mild Cognitive Impairment

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	DONEPEZIL, MEMANTINE

Active Substance Code	NEURO

Protocol Code	CL2-NEURO-005

EudraCT Code	2009-014810-87

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.